Safety of Noncontrast Imaging–Guided Deep Brain Stimulation Electrode Placement in Parkinson Disease

Joacir Graciolli Cordeiro, Anthony Diaz, Jenna Kylene Davis, Daniel Garbin Di Luca, Ghulam Farooq, Corneliu C. Luca, Jonathan Russell Jagid

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Background: Deep brain stimulation (DBS) is considered standard of care for the treatment of medically refractory Parkinson disease (PD). The placement of brain electrodes is performed using contrast imaging to enhance blood vessel identification during stereotactic planning. We present our experience with a series of patients implanted using noncontrast imaging. Methods: All cases of DBS surgery for PD performed between 2012 and 2018 with noncontrast imaging were retrospectively reviewed. Clinical features, postoperative imaging, and complications were analyzed. Results: A total of 287 deep-seated electrodes were implanted in 152 patients. Leads were placed at the subthalamic nucleus and globus pallidus internus in 258 and 29 hemispheres, respectively. We identified 2 cases of intracranial hemorrhage (0.7%). Conclusions: DBS lead placement can be performed without the use of intravenous contrast with a postoperative intracranial hemorrhage rate comparable with other reported series.

Original languageEnglish
Pages (from-to)e1008-e1014
JournalWorld neurosurgery
Volume134
DOIs
StatePublished - Feb 2020

Keywords

  • Contrast
  • Deep brain stimulation (DBS)
  • Hemorrhage
  • Parkinson disease (PD)
  • Safety

Fingerprint

Dive into the research topics of 'Safety of Noncontrast Imaging–Guided Deep Brain Stimulation Electrode Placement in Parkinson Disease'. Together they form a unique fingerprint.

Cite this